Searchable abstracts of presentations at key conferences in endocrinology

ea0056p226 | Calcium & Vitamin D metabolism | ECE2018

Glucose metabolism in primary hyperparathyroidism: The role of parathyroidectomy

Antonopoulou Vasiliki , Grammatiki Maria , Rapti Eleni , Koufakis Theocharis , Karras Spyridon , Yavropoulou Maria , Papavramidis Theodossis , Kotsa Kalliopi

Background: Although primary hyperparathyroidism (PHPT) has been associated with diabetes mellitus (DM), the etiological link is not clear and the effect of parathyroidectomy is controversial.The aim of this observational study was to investigate the metabolic link between calciotropic hormones and glucose metabolism in PHPT patients before and after parathyroidectomy.Methods: Twenty-four consecutive patients with PHPT (Group-A) without DM were included ...

ea0099p188 | Late-Breaking | ECE2024

Relationship of lipoprotein-a levels with the metabolic profile, bone status and kidney function in patients with type 1 diabetes

Kardalas Efstratios , Mpaikousi Dimitra , Mpeka Aikaterini , Antonopoulou Vasiliki , Mouchtouris Panagiotis , Tzanela Marinella

Background/aim: Lipoprotein a (Lpa) is a major atherogenic factor associated with increased cardiovascular risk among patients with type 1 diabetes (t1D). This study investigated the possible relationship of Lpa levels to the metabolic profile, bone status and kidney function of patients with T1D.Materials and methods: 122 adult patients with T1D (70 males and 52 females), were studied in an observational cross-sectional study. Demographic, clinical and ...

ea0056p324 | Clinical case reports - Thyroid/Others | ECE2018

Dapagliflozin and Atkins Diet in a patient with type 2 Diabetes Mellitus: A combination that should be avoided

Grammatiki Maria , Rapti Eleni , Dina Despina , Koufakis Theocharis , Antonopoulou Vasiliki , Tsekmekidou Xanthippi , Yavropoulou Maria , Karras Spyridon , Zebekakis Pantelis , Kotsa Kalliopi

Introduction: Prevalence of type 2 diabetes mellitus (T2DM) rises rapidly worldwide and most patients with T2DM are obese. All treatment algorithms advocate lifestyle modification and weight loss in combination with various therapeutic categories available for the treatment of T2DM, resulting in diet-antidiabetic drug combinations that are not always proper or safe for the patients.Case presentation: A 73-year-old Caucasian man presented to the emergency...

ea0090p759 | Thyroid | ECE2023

Redifferentiation with Vemurafenib of BRAF-mutated Radioiodine Refractory Differentiated Metastatic Thyroid Cancer in two patients

Koukoula Chrysoula , Papalou Olga , Diamantopoulos Aristidis , Beka Aikaterini , Baikousi Dimitra , Antonopoulou Vasiliki , Ntali Georgia , Stratigou Theodora , Rontogianni Phoebe , Datseris Ioannis , Vassiliadi Dimitra , Tsagarakis Stylianos

Radioiodine treatment is the cornerstone of differentiated thyroid cancer (DTC) management. A number of thyroid cancers, however, become radioiodine-refractory (RAIR) and these represent about 60% of advanced DTCs and are responsible for the vast majority of DTC mortality. RAIR DTC has limited therapeutic options, mainly tyrosine kinase inhibitors that are associated with moderate efficacy and considerable toxicity. Reinducing NIS expression (redifferentiation) with the aim of...

ea0063gp16 | Calcium and Bone 1 | ECE2019

The effect of parathyroidectomy on glucose homeostasis and incretin hormone release in patients with primary hyperparathyroidism: a pilot study

Antonopoulou Vasiliki , Grammatiki Maria , Koufakis Theocharis , Karras Spyridon , Yavropoulou Maria , Katsiki Niki , Gerou Spyridon , Gavana Elpida , Skoura Lemonia , Zebekakis Pantelis , Papavramidis Theodosios , Kotsa Kalliopi

Background: Primary hyperparathyroidism (PHPT) has been linked to glucose homeostasis disorders, leading to insulin resistance and type 2 diabetes mellitus. Previous small studies evaluating the effect of parathyroidectomy (PTX) on various parameters of glucose metabolism have produced conflicting results. The impact of PTX on incretin hormone levels has not been studied yet. The aim of this pilot study was to investigate the effect of PTX on markers of glucose metabolism and ...

ea0075a18 | Adrenal gland | EYES2021

Coexistence of bilateral pheochromocytomas, unilateral adrenocortical adenoma and prolactinoma

Diamantopoulos Aristidis , Mourelatos Panagiotis , Partsalaki Eirini , Kanellopoulou Sofia , Papachristou Aglaia , Antonopoulou Vasiliki , Beka Aikaterini , Kyriakopoulos George , Argyro Vassiliadi Dimitra , Tsagarakis Stylianos

Background: An increasing number of mutations are associated with pheochromocytomas. Genetic screening is advocated in all cases and immunohistochemistry as well as phenotype profile recognition may permit a more targeted screening for specific genes.Case Presentation: A 54-year-old male presented with symptoms compatible with pheochromocytoma and increased levels of plasma normetanephrines, metanephrines and 3-methoxytyramine. On Computed Tomography, th...

ea0099ep247 | Endocrine-Related Cancer | ECE2024

Endocrine sequelae of adult recipients of hematopoietic stem cell transplantation

Ntali Georgia , Kardalas Efstratios , Beka Aikaterini , Theodorou Evrydiki , Zotou Maria , Lambraki Anastasia , Tiaka Elisavet , Antonopoulou Vasiliki , Karaolidou Frini , Arapidou Zoi , Vlassopoulou Barvara , Karakasis Dimitrios , Tzenou Tatiana , Tzannou Ifigenia , Tsonis Ioannis , Tzanela Marinella , Gigantes Stavros , Baltadakis Ioannis

Introduction: Hematopoietic stem cell transplantation (HSCT) is the standard of care treatment for high-risk hematological malignancies. HSCT recipients are exposed to chemotherapy and/or radiation prior to HSCT, as part of the conditioning, or following HSCT for management of disease relapse. They may receive steroids for chronic graft-versus-host disease (cGvHD) and they are at high risk for endocrine complications. Aim: To evaluate endocrine complicat...